ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

Collaborations in Neurosurgery: MRI Interventions' ClearPoint System and Monteris Medical's NeuroBlate System Utilized Jointly to Enable Laser Ablation of Brain Tumor

Print | 
Email |  Comment   Share  

MRI Interventions, Inc
One Commerce Square
Memphis, TN, 38103

Press release date: June 23, 2014

First Joint Utilization of the Two Technologies Facilitates Technically Simple, Minimally Invasive Ablative Surgery for Brain Tumor at UCSD

IRVINE, Calif. and MINNEAPOLIS - MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Corp. jointly announced the utilization of their respective product platforms, the ClearPoint® Neuro Intervention System and the NeuroBlate® System, at UC San Diego Health System to enable minimally invasive (MR-guided) laser treatment in a patient afflicted with glioblastoma, a type of brain tumor. In a procedure led by Dr. Clark Chen, MD, PhD, Chief of Stereotactic and Radiosurgery and Vice-Chairman of Academic Affairs, MRI Interventions' ClearPoint System was used to establish the path to the tumor while Monteris' NeuroBlate System was used to ablate (heat) tumor cells. The entire procedure was performed within a diagnostic MRI suite at UC San Diego Health System.

The NeuroBlate® System from Monteris is a MRI-guided system which allows surgeons to use lasers in a minimally invasive manner to destroy brain tumors. The System interfaces with an active MRI for visualization of the target area to enable surgical decision-making.

The ClearPoint System is the only available navigation platform that allows neurosurgeons to operate under continuous intraprocedural MRI guidance. The direct visualization of events as they occur during surgery allows neurosurgeons to observe the progression of instruments and devices in relation to the patient's anatomy and to make adjustments in real time. This MRI-guided intraoperative navigation is made possible by the ClearPoint System.

Using the ClearPoint System, Dr. Chen was able to see and select the tumor in the brain, establish the desired trajectory, and visualize the NeuroBlate laser probe on MR images as it was inserted into the tumor. He then engaged the NeuroBlate System's laser probe and the Monteris M*Vision™ software with real-time MR thermometry to monitor destruction of the tumor cells.

MRI Interventions' Business Development Manager and clinical engineer Geoffrey Bates attended the first case. "The two products worked together seamlessly," said Bates. "I was very pleased to see that our efforts to establish compatibility have resulted in a laser ablation procedure which can occur completely within a diagnostic MRI suite."

"We are happy to announce the completion of this NeuroBlate System with ClearPoint joint case," stated John Schellhorn, President and Chief Executive Officer of Monteris. "Our customers are eager to use tools that make surgical visualization and targeted therapy easier. We look forward to many more successful collaborations in the future."

Kim Jenkins, Chief Executive Officer of MRI Interventions, said, "This case is representative of the kind of partnerships that drive innovation in our field. Working together, we can help physicians change patients' lives for the better."

About the NeuroBlate System®

The NeuroBlate System is FDA-cleared to ablate, necrotize or coagulate soft tissue encountered in the discipline of neurosurgery through the application of thermal therapy. The NeuroBlate System is a tool, and not a treatment, which is used by physicians to address various medical conditions including brain tumors. This press release discusses glioblastoma multiforme type brain tumors. The NeuroBlate System is not indicated to treat, cure, prevent, mitigate or diagnose any specific disease, including glioblastoma multiforme. Full prescribing information for the NeuroBlate System is available at

About Monteris Medical, Corp.

Monteris Medical is a privately held company developing devices for minimally-invasive, MR-guided neurosurgery. Monteris markets the NeuroBlate® System for controlled, volumetric ablation of brain lesions. Monteris also offers the AXiiiS® Stereotactic Miniframe; a single use platform for image-guided trajectory alignment, and the AtamA™ Stabilization System for MR based procedures requiring versatile head fixation.

About MRI Interventions, Inc.

Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint® system is designed to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. For more information, please visit

MRI Interventions Contact Information:
David Carlson, CFO

Monteris Medical Contact Information:
Kathryn Meintsma, VP Marketing

Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


Post a comment about this story

(your e-mail address will not be posted)
Comment title:
To submit comment, enter the security code shown below and press 'Post Comment'.

 See related product stories
More .....
 See more product news in:
Health, Medical and Dental Supplies and Equipment
| Featured Manufacturing Jobs
 Other News from this company:
UC San Diego Health System Utilizes Platform Capabilities of MRI Interventions' ClearPoint System to Conduct Three Back-to-Back Procedures on a Single Patient
MRI Interventions to Exhibit Its ClearPoint System for Real-Time MRI-Guided Brain Surgery at American Society for Stereotactic and Functional Neurosurgery Biennial Meeting
MRI Interventions to Exhibit Its ClearPoint Neuro Intervention System at AANS 2014 Annual Meeting
MRI Interventions' ClearTrace System to Be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Surgical Equipment & Supplies

Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy

Error close

Please enter a valid email address